Complete FDA and NHTSA recall records dated in February 2020.
These records include useful source details for the selected month.
The products are being recalled due to reports of breakage broke at the point of a welded joint either prior to use during setup or during use inside the patient's mouth.
There is the potential for various failures with the LOR (loss of resistance) syringes included in the kits resulting in dural puncture with some also requiring a blood patch.
There is the potential for various failures with the LOR (loss of resistance) syringes included in the kits resulting in dural puncture with some also requiring a blood patch.
A defect involving an occluded needle was discovered during a training exercise.
There is the potential for various failures with the LOR (loss of resistance) syringes included in the kits resulting in dural puncture with some also requiring a blood patch.
The devices may be missing the implant coil.
Potentially undeclared Yohimbe 83 and complaints of adverse reactions: upset stomach, jittery, sweaty, lightheaded or dizzy.
They were notified by their supplier that the product may be contaminated with foreign material.
Incorrect ingredient label was put on salad product and does not declare eggs and wheat.
Product is being recalled due to potentially elevated levels of histamines.
Canisters containing Iodized Salt are labeled with Plain Salt labels, causing dextrose and potassium iodide to be undeclared ingredients.
Possible L. mono contamination in hard boiled eggs
Labeling: Label Lacks Warning: Product recalled due to absence of a warning statement on the product label, Ask a doctor before use if you have a sodium-restricted diet.
Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.
Failed Dissolution Specifications: Low out of specification results obtained during stability testing.
Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture…
Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture…
Defective Container: confirmed customer reports for vials with loose metal overseal crimp defects, which may result in lack of assurance of sterility.
Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product.
Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.
Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count…
Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie
Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
